A. Velasco Sendra-rekin lankidetzan egindako argitalpenak (5)

2012

  1. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 4, pp. 435-441

2010

  1. Response to rupatadine and heart rhythm disturbances

    Clinical Pharmacology and Therapeutics

2009

  1. Heart rhythm disturbances associated with rupatadine: A case series from the Spanish and Portuguese pharmacovigilance systems

    Clinical Pharmacology and Therapeutics, Vol. 85, Núm. 5, pp. 481-484

2007

  1. Gynaecomastia associated with proton pump inhibitors: A case series from the Spanish pharmacovigilance system

    Drug Safety, Vol. 30, Núm. 6, pp. 527-531

2006

  1. HMG CoA reductase inhibitors and impotence: Two case series from the Spanish and French drug monitoring systems

    Drug Safety, Vol. 29, Núm. 2, pp. 143-149